Suicides in National Hormone Pituitary Program Recipients of Cadaver-Derived Human Growth Hormone
Open Access
- 31 October 2023
- journal article
- research article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 7 (12) , bvad130
Abstract
Context: Numerous reports of suicide among individuals who received cadaver-derived human growth hormone (c-hGH) through the National Hormone Pituitary Program (NHPP) raised the alarm for potentially increased suicide risk. Objective: We conducted a study to assess suicide risk in the NHPP cohort and identify contributing factors to facilitate early recognition and intervention. Methods: The study population consisted of patients receiving NHPP c-hGH starting from 1957, and cohort deaths with an ICD code consistent with suicide or possible suicide through 2020 were evaluated. Descriptive data were extracted from medical records. Standardized mortality ratios (SMRs) to compare the observed number of suicide deaths in the cohort to the expected number were calculated using general population suicide rates by sex, age group, and time period. Results: Among 6272 patients there were 1200 all-cause cohort deaths, of which 55 (52 male, 3 female) were attributed to suicide. Of these, 47 were identified by ICD code alone compared to an expected count of 37.8 (SMR = 1.25, 95% CI 0.91-1.66). Among male cohort members, the SMR was 1.33 (95% CI 0.97-1.78). Elevated risk of suicide was detected for cohort members aged 25-34 (SMR = 1.79, 95% CI 1.06-2.83) and during the period from September 19, 1985, to December 31, 1998 (SMR = 1.70, 95% CI 1.02-2.65). Conclusion: Overall, the observed number of suicides among NHPP c-hGH recipients was not significantly higher than expected. However, certain subgroups may be at elevated risk of suicide. Studies are needed to better understand the nature and magnitude of suicide risk among c-hGH recipients to facilitate early intervention to prevent suicide deaths.Keywords
This publication has 23 references indexed in Scilit:
- Evaluation of Potential Infectivity of Alzheimer and Parkinson Disease Proteins in Recipients of Cadaver-Derived Human Growth HormoneJAMA Neurology, 2013
- The influence of disability on suicidal behaviourALTER - European Journal of Disability Research / Revue Européenne de Recherche sur le Handicap, 2012
- Physical stature and method-specific attempted suicide: Cohort study of one million menPsychiatry Research, 2010
- Alcohol use disorders increase the risk of completed suicide — Irrespective of other psychiatric disorders. A longitudinal cohort studyPsychiatry Research, 2009
- Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studiesDrug and Alcohol Dependence, 2004
- Long-term mortality in the United States cohort of pituitary-derived growth hormone recipientsThe Journal of Pediatrics, 2004
- THE IMPACT OF LONG‐TERM THERAPY BY A MULTIDISCIPLINARY TEAM ON THE EDUCATION, OCCUPATION AND MARITAL STATUS OF GROWTH HORMONE DEFICIENT PATIENTS AFTER TERMINATION OF THERAPYClinical Endocrinology, 1987
- Potential Epidemic of Creutzfeldt–Jakob Disease from Human Growth Hormone TherapyNew England Journal of Medicine, 1985
- Final Stature in Brain Tumours Other than Craniopharyngioma: Effect of Growth HormoneHormone Research, 1985
- Final Height of Patients with Pituitary Growth Failure and Changes in Growth Variables after Long Term Hormonal TherapyPediatric Research, 1983